After a strong 6 months that has seen the best growth spurt in its history, Lonza is raising its guidance for the rest of the year.

Germany’s hybrid CRO-biotech Evotec has had a better few months than expected as it announces stronger profits for 2016 ahead of its half-year results on Aug.…

CRO giant Parexel has posted new growth figures showing it looks to grow by 10% to 12% each year, spurred by both ongoing ops and growth from recent buys.

San Diego- and China-based BioDuro, which merged with San Diego’s Formex late last year, announced at BIO this week its formal acquisition of Formex to form…

Icon saw steady growth of 3.1% for the first quarter as sales just tipped the $400 million mark.

With news reports suggesting Pfizerhas killed off its planned $160 billion megamerger with Allergan after a crackdown from the U.S. Treasury, CROs may have a…

PRA Health Sciences posted a solid set of financials for the fourth quarter as it predicts double-digit growth in the coming year.

Covance has helped buoy LabCorp earnings in the fourth quarter as its leadership team hails a "transformative year."